Hinge Health, Inc.
HNGENYSECIK 1673743TechnologyFiscal year ends Dec 31
Reports and events: 23 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2120:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-058439 |
| 2026-08-0620:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054327 |
| 2026-08-0420:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052558 |
| 2026-06-0920:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-041886 |
| 2026-06-0420:19 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-040802 |
| 2026-05-0720:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032224 |
| 2026-05-0520:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-030499 |
| 2026-04-1712:04 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001628280-26-025602 |
| 2026-03-1720:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-018710 |
| 2026-03-0321:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-013808 |
| 2026-02-1021:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006826 |
| 2025-11-1214:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-276208 |
| 2025-11-0721:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272353 |
| 2025-11-0421:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264667 |
| 2025-08-1320:15 ET | 8-K | 8.01 Other events | 0000950170-25-108048 |
| 2025-08-1120:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106577 |
| 2025-08-0520:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-103024 |
| 2025-05-2321:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-125916 |
| 2025-05-1621:28 ET | S-1/A | Registration statement, amended | 0001193125-25-121827 |
| 2025-05-1310:19 ET | S-1/A | Registration statement, amended | 0001193125-25-118259 |
| 2025-05-0521:08 ET | S-1/A | Registration statement, amended | 0001193125-25-112887 |
| 2025-04-0721:11 ET | S-1/A | Registration statement, amended | 0001193125-25-074751 |
| 2025-03-1020:45 ET | S-1 | Registration statement | 0001193125-25-051004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.